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Abstract
Background: Articular cartilage undergoes an important maturation process from neonate to
adult that is reflected by alterations in matrix protein organization and increased heterogeneity of
chondrocyte morphology. In the horse, these changes are influenced by exercise during the first
five months of postnatal life. Transcriptional profiling was used to evaluate changes in articular
chondrocyte gene expression during postnatal growth and development.
Methods: Total RNA was isolated from the articular cartilage of neonatal (0–10 days) and adult
(4–5 years) horses, subjected to one round of linear RNA amplification, and then applied to a 9,367-
element equine-specific cDNA microarray. Comparisons were made with a dye-swap experimental
design. Microarray results for selected genes (COL2A1, COMP, P4HA1, TGFB1, TGFBR3, TNC)
were validated by quantitative polymerase chain reaction (qPCR).
Results: Fifty-six probe sets, which represent 45 gene products, were up-regulated (p < 0.01) in
chondrocytes of neonatal articular cartilage relative to chondrocytes of adult articular cartilage.
Conversely, 586 probe sets, which represent 499 gene products, were up-regulated (p < 0.01) in
chondrocytes of adult articular cartilage relative to chondrocytes of neonatal articular cartilage.
Collagens, matrix-modifying enzymes, and provisional matrix non-collagenous proteins were
expressed at higher levels in the articular cartilage of newborn foals. Those genes with increased
mRNA abundance in adult chondrocytes included leucine-rich small proteoglycans, matrix
assembly, and cartilage maintenance proteins.
Conclusion: Differential expression of genes encoding matrix proteins and matrix-modifying
enzymes between neonates and adults reflect a cellular maturation process in articular
chondrocytes. Up-regulated transcripts in neonatal cartilage are consistent with growth and
expansion of the articular surface. Expression patterns in mature articular cartilage indicate a
transition from growth to homeostasis, and tissue function related to withstanding shear and
weight-bearing stresses.
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At birth, articular cartilage is relatively homogeneous.
That is, the cellular and molecular structures do not vary
from site to site topologically across the joint [1-6]. Dur-
ing postnatal maturation in mammals, articular cartilage
undergoes architectural reorganization associated with
growth and changes in biomechanical demands on the
tissue [1-3,5]. For equine articular chondrocytes, the proc-
ess is characterized by altered matrix protein production
patterns with exercise during the first five months of post-
natal life [2,7]. This adaptation affects the tissue longitu-
dinally from the joint surface to deeper layers, as well as
topologically across a joint between weight-bearing and
non-weight-bearing areas [1,2,8]. Sites that receive low-
level constant weight-bearing load have higher amounts
of glycosaminoglycan and proteoglycan, providing resist-
ance to compressive stresses [1,8]. Sites that receive high
sheer stress through intermittent peak loading and move-
ment have high levels of type II collagen for tensile
strength [1,8]. As noted, these changes in architectural
heterogeneity develop in the articular cartilage of foals
during the first 5 months of life [2,3]. However, if exercise
is restricted, articular cartilage fails to fully develop these
characteristics of maturation. In addition, re-establishing
normal levels of activity in a previously exercise-restricted
foal is ineffective at promoting proper articular cartilage
adaptation [2,3]. In this same population of horses, van
den Hoogen et al. found that proteoglycan synthesis
increased with free pasture exercise over the first 5 months
followed by a light exercise regimen [9]. These results sug-
gest that the architecture of articular cartilage changes
with age and mechanical stimulation. If normal exercise is
severely restricted in a horse during the first 5 months of
postnatal life, then adaptation of matrix and anchorage
proteins in articular cartilage to weight- and shear-stresses
can be permanently compromised.
Postnatal articular cartilage changes have been character-
ized in several mammals. The transition from isotropic to
anisotropic architecture was demonstrated in the articular
cartilage of the proximal tibia of rats by Sasano et al. and
in the medial femoral condyle of rabbits by Hunziker et al.
[5,10]. Increased postnatal matrix deposition of type II
collagen occurs in the rabbit and rat [10,11]. Changes and
topological differences in cross-linking of collagens with
age in postnatal horses as well as in humans have been
established [7,8,12]. Moreover, moderate exercise in
young adult dogs, guinea pigs, and humans seem to cause
zonal changes in proteoglycan and collagen content that
allow for adaptation and strengthening of articular carti-
lage [13]. While past studies have described biochemical
and histological changes to articular cartilage during the
postnatal period, much remains unexplained with regards
to the cellular mechanisms that achieve growth and
matrix re-organization. The current study utilizes microar-
ray-based transcriptional profiling to assess differential
gene expression between neonatal and mature articular
cartilage across a large subset of genes in the equine
genome. In addition to individual genes, including those
with established functional annotation in cartilage, the
approach enables expression differences between gene
ontology categories to be compared. The hypothesis
tested was that changes in chondrocyte gene expression
occur during postnatal maturation and reflect a functional
transition from growth and matrix synthesis to cartilage
homeostasis.
Materials and methods
Cartilage Collection and RNA Isolation
Full-thickness articular cartilage was harvested and pooled
from the proximal and distal humerus, the proximal and
distal femur, the proximal and distal tibia, proximal
radius, and proximal ulna of seven 0–10 day old foals and
nine 4–5 year old adults. In the foals, particular attention
was paid to distinguish regions with and without cartilage
canals because articular cartilage with vasculature is des-
tined to become calcified cartilage or to undergo hyper-
trophic differentiation and the formation of bone. Only
cartilage without vascular canals was utilized in this study.
Cartilage was rinsed in sterile phosphate-buffered saline,
snap-frozen in liquid nitrogen, and then pulverized into
powder while still frozen. Total RNA was isolated in a
buffer of 4 M guanidinium isothiocyanate, 0.1 M Tris-
HCl, 25 mM EDTA (pH 7.5) with 1% (v/v) 2-mercap-
toethanol, followed by differential alcohol and salt pre-
cipitations [14-16]. Finally, RNA samples were re-purified
using QIAGEN RNeasy columns following the manufac-
turer's protocol.
Transcriptional Profiling
Microarray slides were printed with clones selected from a
cDNA library generated using mRNA purified from the
articular cartilage of a 15-month old Thoroughbred male
[17]. Creation of the cDNA library is described in Cole-
man et al. [18]. Probe sets on the microarray slides were
prepared and printed as described by Band et al. [19].
Transcriptional profile differences of neonatal and mature
articular chondrocytes were assessed by four separate
neonate-adult comparisons. For each experimental sam-
ple, 2 μg of total RNA received one round of linear ampli-
fication primed with oligo-dT (Invitrogen – SuperScript
RNA Amplification System) [20,21]. Amplified RNA (2
μg) was then used as template to create fluorescent dye-
coupled single-stranded aminoallyl-cDNA probes (Invit-
rogen – Superscript Indirect cDNA Labeling System,
Molecular Probes – Alexa Fluor 555 and 647 Reactive
Dyes).
Microarray slides were pre-hybridized in 20% formamide,
5× Denhardt's, 6× SSC, 0.1% SDS, and 25 μg/ml tRNA forPage 2 of 14
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then washed five times in deionized water and once in
isopropanol and spun dry at 700 g for 3 minutes [19].
Two dye-coupled fluorescent cDNA probes representing
one of each of the two experimental groups (neonate vs.
adult) were combined with 1× hybridization buffer (1×
Slide Hybridization Buffer #1, Ambion, cat no. 8801),
incubated for 2 minutes at 95°C, and then applied to the
slide under a glass lifterslip for 48 hours at 42°C. All
hybridizations were performed in duplicate with a dye
swap to eliminate possible dye bias [22]. Post-hybridiza-
tion washes were each for 5 minutes as follows: first wash
– 1× SSC, 0.2% SDS, 0.1 mM DTT at 42°C; second wash
– 0.1× SSC, 0.2% SDS, 0.1 mM DTT at room temperature;
third and fourth washes – 0.1× SSC and 0.1 mM DTT at
room temperature. After the post-hybridization washes,
the slides were spun dry under argon gas at 700 g for 3
minutes. Each slide was coated once in DyeSaver 2 (Gen-
isphere) and allowed to dry for 10 minutes. Scanning was
performed using a GenePix 4100A scanner with the spot
intensities computed using GENEPIX 6.0 image analysis
software (Axon Instruments/Molecular Devices).
Statistics and Analysis
After scanning, median intensities adjusted for back-
ground for each pair of spots were lowess-normalized for
every slide using the bottom row of each of the 48 printing
blocks. This bottom row contains a constant set of posi-
tive and negative controls. A one sample t-test was applied
to the log ratios accounting for dye-swapped slides. Corre-
sponding microarray IDs for statistically significant probe
sets were queried with an annotation database [23]. The
data extracted were putative gene symbols and gene
descriptions from a series of BLAST searches of the ESTs to
the curated protein, RNA, and genomic Reference
Sequence Databases [24]. Gene ontology (GO) annota-
tion was derived from batch queries of the DAVID Bioin-
formatics tool or manually through individual NCBI
Entrez Gene queries [25,26]. Statistical data, fold change
quantities, and GO annotations were managed within an
Excel spreadsheet (Microsoft, Redmond, WA). Expression
patterns were analyzed using Expression Analysis System-
atic Explorer (EASE) standalone software [27]. Microarray
data were submitted to NCBI Gene Expression Omnibus
as the data series GSE10303 for platform GPL6423 with
sample accessions GSM260356, GSM260358, GSM2603
61, and GSM260363 [28].
Validation of Microarray Hybridization Results with qPCR
Differential expression for selected genes was validated via
quantitative polymerase chain reactions (qPCR). Briefly,
total RNA was reverse-transcribed (RT) into cDNA using
an oligo-dT primer with the Promega Reverse Transcrip-
tion System (Promega, cat. no. A3500). Quantitative
"real-time" PCR (ABI Systems 7900HT Fast Real-Time
PCR System, Applied Biosystems, Foster City, CA) was
performed using TaqMan Gene Expression Master Mix
(Applied Biosystems, cat. no. 4369016) and intron-span-
ning primer/probe sets (Assays-by-Design, Applied Bio-
systems) created from equine genomic sequence data
(Ensembl – http://www.ensembl.org/Equus_caballus/ind
ex.html; UCSC Genome Browser – http://genome.ucsc.e
du) (Table 1). Each primer/probe set was tested for specif-
icity and performance and had to meet two criteria: (1) no
amplification with genomic DNA, minus-RT, and water
controls; and (2) amplification efficiencies within a range
of 0.9–1.2 as determined by manual serial dilution of a
positive control sample, following Applied Biosystems
recommended performance guidelines. All primer/probe
sets met these specificity and performance criteria. Beta-2-
microglobulin (B2M), beta-glucuronidase (GUSB), phos-
phoglycerate kinase 1 (PGK1), and large ribosomal pro-
tein P0 (RPLP0) primer/probe sets were evaluated as
potential endogenous control transcripts. Steady state lev-
els of mRNA encoding type II procollagen (COL2A1), car-
tilage oligomeric matrix protein (COMP), proline 4-
hydroxylase (P4HA1), transforming growth factor beta
receptor-3 (TGFβR3), and tenascin-C (TNC) were selected
for RT-qPCR validation based on EASE data analyses.
Transforming growth factor beta-1 (TGFβ1) was selected
as a transcript of biological interest that did not demon-
strate an expression difference by microarray hybridiza-
tions. Results were adjusted for efficiency as measured by
LinRegPCR using the default fit option which measures
the slope of a line containing 4–6 data points and the
highest R2 correlation value [29,30]. Real-time PCR data
were normalized with endogenous control genes GUSB
and RPLP0 according to guidelines set by geNorm stabil-
ity analyses [31]. Relative expression levels by RT-qPCR
using all 10 equine-specific primer/probe sets were deter-
mined individually on 7 neonatal and 9 adult articular
cartilage RNA samples. This included the original 4 neo-
natal and 4 adult articular cartilage RNA samples used in
the microarray comparisons. A non-parametric Mann-
Whitney-Wilcoxon Rank Sum Test was used to assess sta-
tistical significance of qPCR results.
Results
Global assessment of transcriptome differences
Nine thousand three hundred sixty-seven probe sets were
analyzed. A total of 642 probe sets (6.9%) were differen-
tially expressed (p < 0.01; Figure 1b). A volcano plot
shows that 586 probe sets (representing 499 different
genes) were up-regulated in adult chondrocytes relative to
neonates, while 56 probe sets (representing 45 different
genes) of the differentially expressed clones were up-regu-
lated in neonate chondrocytes relative to adults (Figure
1c). Based on a p-value of 0.01, we would expect up to 94
(1% of 9,367) to be differentially expressed by chance,Page 3 of 14
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2008, 9:149 http://www.biomedcentral.com/1471-2474/9/149yielding a False Discovery Rate (FDR) of 14.64% (94/
642).
Functional patterns of differential gene expression
Significant genes with a > 2 fold difference in either direc-
tion (neonate > adult, adult > neonate) were analyzed by
Expression Analysis Systematic Explorer (EASE) (Table 2).
Overrepresentation was determined by EASE score, a
Fisher's exact test measure. Gene overrepresentation was
strongest for extracellular and extracellular matrix catego-
ries (Table 2). Differential expression was also represented
in categories involving skeletal development, cell adhe-
sion, heparan sulfate proteoglycan metabolism, as well as
receptor activity and organogenesis. Categories not over-
represented in this analysis, however, include growth fac-
tor activity and cell proliferation.
Cartilage matrix proteins and modifying enzymes
Many of the differentially expressed transcripts identified
in the annotation categories are cartilage matrix proteins.
Collagen types II (COL2A1), and IX (COL9A1, COL9A2,
COL9A3), and tenascin-C (TNC) were upregulated in
neonatal chondrocytes relative to adult chondrocytes
(Table 3). Other genes demonstrating greater transcript
abundance in neonates relative to adults include collagen-
modifying enzymes like lysyl oxidase-like 2 (LOXL2), pro-
line-4-hydroxylase alpha 1 subunit (P4HA1), and the
basement membrane protein nidogen-2 (NID2) (Table
3). Transcripts encoding matrix proteins that are more
abundant in adults include chondroadherin (CHAD), car-
tilage intermediate layer protein (CILP), cartilage oligo-
meric matrix protein (COMP), fibronectin (FN), frizzled-
related protein (FRZB), and procollagen C-endopeptidase
enhancer 2 (PCOLCE2) (Table 4). Redundant cDNA
probe sets present on the microarray displayed strong
concordance.
Growth factors
With the exception of transforming growth factor-beta
receptor 3 (TGFβR3) and fibroblast growth factor 10
(FGF10), no transcripts encoding growth factors or
growth factor receptors showed > 2 fold-difference on the
microarray hybridizations (Table 5). Several additional
growth factors and growth factor receptors (FGFRL1,
GDF5, GDF6, IGF2R, IGFBP5) demonstrated a significant
change in steady state mRNA levels (p < 0.01), but with
only minimal fold change differences between neonatal
and adult samples (Table 5).
Quantification of differential gene expression with real-
time qPCR
Steady state transcript abundance was measured for
potential endogenous control genes B2M, GUSB, PGK1,
and RPLP0. Messenger RNA levels for all 4 of these genes
were similar (p > 0.05) between neonates and adults by
the microarray hybridizations. Stability was also assessed
by geNorm VBA applet, and RPLP0 and GUSB were the
two most stable endogenous control gene candidates (M
= 0.552). As a result, they were selected as the most suita-
Table 1: Primer nucleotide sequences used in RT-qPCR assays for genes described in the study
Gene Name Gene Symbol Forward Primer Reverse Primer
Beta-2-microglobulin B2M 5-CGGGCTACTCTCCCTGACT-3 5-GTGACGTGAGTAAACCTGAACCTT-3
Beta-glucuronidase GUSB 5-GCTCATCTGGAACTTTGCTGATTTT-3 5-CTGACGAGTGAAGATCCCCTTTT-3
Phosphoglycerate kinase-1 PGK1 5-GTGGCCTCTGGCATACCT-3 5-CTGCTCTCAGTGCCACAGT-3
Ribosomal protein, large, P0 RPLP0 5-CTGATTACACCTTCCCACTTGCT-3 5-AGCCACAAATGCAGATGGATCA-3
Procollagen, type II, alpha 1 COL2A1 5-CTGGCTTCAAAGGCGAACAAG-3 5-GCACCTCTTTTGCCTTCTTCAC-3
Cartilage oligomeric matrix protein COMP 5-CGAGCCCGGCATCCA-3 5-CCCAGGGCCTGTGGAG-3
Proline-4-hydroxylase, alpha 1 P4HA1 5-CCTGTCCAGTGCTAGTAGGAAAC-3 5-CCTGTCCAGTGCTAGTAGGAAAC-3
Transforming growth factor beta-1 TGFβ1 5-CCCTGCCCCTACATTTGGA-3 5-TGTACAGGGCCAGGACCTT-3
Transforming growth factor beta 
receptor 3
TGFβR3 5-ACATCATCGAGTTAATCACCCCAAA-3 5-GATCCTTTCGAGAAGGTCTTATGTCA-3
Tenascin-C TNC 5-TCAGCCATCACTACCAAGTTCAC-3 5-GAACCTCAGTAGCAGTCAAATCTCT-3Page 4 of 14
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biological interest further analyzed by RT-qPCR.
Five mRNA transcripts (COL2A1, COMP, P4HA1,
TGFβR3, TNC) that displayed differential expression in
the microarray hybridizations and one transcript (TGFβ1)
that did not were selected for RT-qPCR validation (Figure
2). These genes were selected to confirm the microarray
findings and because of the functional annotation of their
encoded proteins. Relative quantification of target tran-
scripts revealed significant increases in neonatal mRNA
abundance for COL2A1, P4HA1, and TNC (Figure 2).
Fold change differences were similar or slightly greater
than what was measured by microarray profiles. Moreo-
ver, increased COMP and TGFβR3 transcript abundance
for adult cartilage was also validated by RT-qPCR while
TGFβ1 confirmed the microarray finding of no significant
difference (Figure 2).
Discussion
Transcriptional profiling results indicate that maturation-
dependent differences in cellular activity exist between
neonatal and adult equine articular chondrocytes. These
differences likely reflect age-dependent adaptation that
occurs as chondrocytes are acting to meet changing func-
tional needs. Neonatal articular cartilage is in a state of
cDNA microarray transcriptional profiling indicates differential gene expression between neonatal and adult articular cartilageFigure 1
cDNA microarray transcriptional profiling indicates differential gene expression between neonatal and adult 
articular cartilage. (a) Histomorphometric comparison of isotropic articular cartilage structure in the equine neonate and 
the anisotropic structure in adults. (b) A p-value histogram of differentially expressed transcripts from the 9,367 element 
equine-specific cDNA microarray demonstrates that just under 7% of the clones had significance at p < 0.01. (c) A volcano plot 
of the neonatal versus adult comparison; points above the horizontal black line are transcripts demonstrating differential 
expression with a significance of p < 0.01. The two vertical black lines correspond to 2-fold up- and down-regulation. Degree 
of statistical significance is displayed along the vertical axis and expression fold change along the horizontal axis.Page 5 of 14
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Table 2: EASE analysis of genes with significant fold differences greater than 2
GO System Gene Category List Hits List Total Population Hits Population Total EASE Score Official Gene 
Symbols
Cellular Component Extracellular 19 37 258 2760 3.27E-10 CHAD, CILP, CLU, 
COL2A1, COL9A1, 
COMP, CP, FMOD, 
FN1, FRZB, GAS6, 
LOXL2, NID2, PRELP, 
SERPINA5, SULF1, 
THSD1, TIMP2, TNC
Cellular Component Extracellular Matrix 11 37 101 2760 3.17E-07 CHAD, COL2A1, 
COL9A1, COMP, 
FMOD, FN1, NID2, 
PRELP, THSD1, TIMP2, 
TNC
Molecular Function Extracellular Matrix 
Structural Constituent
6 40 35 2830 9.16E-05 CHAD, COL2A1, 
COL9A1, COMP, FN1, 
PRELP
Biological Process Skeletal Development 6 38 55 2780 0.00068 ANKH, COL2A1, 
COMP, DLX5, FRZB, 
PRELP
Biological Process Cell Adhesion 8 38 151 2780 0.00315 COL2A1, COL9A1, 
COMP, FN1, LOXL2, 
NID2, THSD1, TNC
Cellular Component Extracellular Space 5 37 71 2760 0.01273 CP, FN1, LOXL2, 
SERPINA5, SULF1
Biological Process Development 11 38 410 2780 0.03681 ANKH, BOC, CLU, 
COL2A1, COL9A1, 
COMP, DLX5, FRZB, 
LOXL2, PRELP, 
TGFBR3
Biological Process Heparan Sulfate 
Proteoglycan 
Metabolism
2 38 5 2780 0.06484 HS3ST3A1, SULF1
Biological Process Acute-phase Response 2 38 6 2780 0.07731 FN1, SERPINA5
Molecular Function Scavenger Receptor 
Activity
2 40 6 2830 0.07996 KIAA1822, LOXL2
Biological Process Organogenesis 7 38 231 2780 0.08131 ANKH, COL2A1, 
COL9A1, FRZB, PRELP
Molecular Function Transmembrane 
Receptor Activity
5 40 122 2830 0.08470 FRZB, KIAA1822, 
LOXL2, PDGFRL, TNC
Molecular Function Receptor Activity 7 40 233 2830 0.09626 FRZB, KIAA1822, 
LOXL2, NR1D2, 
PDGFRL, TGFBR3, 
TNC
"GO System" represents the major ontological system (i.e., cellular component, biological process, or molecular function). "Gene category" is a 
descriptive term shared by a group of genes. "List hits" are the numbers of differentially abundant transcripts that belong to the gene category. "List 
total" is the number of differentially expressed genes within the corresponding cellular component, biological process, or molecular function 
system. "Population hits" represent the total number of genes found on the microarray possessing that specific gene category annotation (e.g., 
extracellular, skeletal development, etc.). "Population Total" represents the total number of genes found on the microarray possessing that GO 
system annotation. "EASE score" is a measure of overrepresentation that scales the results of a statistical analysis (Fisher's exact test) by biasing 
against categories supported by few genes. Gene symbols of differentially expressed probe sets represented for each gene category are given in the 
last column.
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Table 3: Cartilage matrix proteins and modifying enzymes upregulated in neonatal cartilage relative to adult cartilage
Gene Name Gene Symbol GenBank ID(s) Fold Change (N/A) p-value
Procollagen, type II alpha 1 COL2A1 CX594994.1 2.77 0.0161
CX595082.1 2.31 0.0454
CX595094.1 7.86 0.0037
CX596509.1 3.74 0.0059
CX597852.1 2.62 0.0503
CX599228.1 2.70 0.0557
CX599236.1 2.68 0.0402
CX600104.1 2.64 0.0546
CX601257.1 3.43 0.0192
CX602198.1 2.72 0.0488
CX603857.1 2.43 0.0758
CX604122.1 2.93 0.0246
CX604856.1 2.19 0.0310
CX605192.1 1.75 0.0055
CX605350.1 2.68 0.0447
CX605856.1 8.10 0.0040
Procollagen, type IX COL9A1 CX602049.1 4.61 0.0029
CX605273.1 6.70 0.0108
COL9A2 CX597674.1 2.11 0.0304
COL9A3 CX594271.1 1.93 0.0083
CX603177.1 1.41 0.0889
Lysyl oxidase-like 2 LOXL2 CX600483.1 2.98 0.0051
CX598127.1 2.52 0.0033
Nidogen-2 NID2 CX596324.1 2.71 0.0003
CX600869.1 2.31 0.0037
Proline 4-hydroxylase, alpha 1 P4HA1 CX605971.1 2.38 < 0.0001
CX592418.1 2.23 < 0.0001
Tenascin-C TNC CX593372.1 4.81 0.0043
CX601743.1 2.74 0.0430
CX601953.1 2.25 0.0715
CX603922.1 3.09 0.0062
CX604542.1 2.39 0.0016
CX605854.1 4.72 0.0054
Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; GenBank ID: Accession number of equine cDNA 
spotted on the microarray; Fold Change (N/A): Relative Neonate/Adult fold change; p-value: one-sample t-test p-value for probe across the four 
biological replicates in the total sample set.
BMC Musculoskeletal Disorders 2008, 9:149 http://www.biomedcentral.com/1471-2474/9/149growth and expansion. The chondrocytes are secreting
large amounts of extracellular matrix (ECM) in response
to the expanding articular surface. This can be seen with
the upregulation of collagen types II and IX in neonatal
chondrocytes. Microarray hybridization data showing
increased abundance of type II collagen transcripts in neo-
natal articular cartilage relative to adult articular cartilage
was validated at 3.75-fold by RT-qPCR (p < 0.01, Figure
2).
In neonatal articular chondrocytes, there is also an upreg-
ulation of collagen-modifying enzymes necessary for the
assembly of ECM; this includes proline 4-hydroxylase
(P4H) and lysyl oxidase. P4H is a catalyst necessary for the
modification of proline for collagen triple helix formation
[32]. Increased transcript abundance for P4HA1 indicated
by microarray in neonatal articular cartilage relative to
adult articular cartilage was validated at 3.71-fold by RT-
qPCR (p < 0.01, Figure 2). Lysyl oxidases catalyze the
cross-linking and condensation of collagen fibrils by oxi-
Table 4: Cartilage matrix proteins and modifying enzymes upregulated in adult cartilage relative to neonatal cartilage
Gene Name Gene Symbol GenBank ID(s)† Fold Change (A/N) p-value
Cartilage intermediate layer protein CILP CX598636.1 5.96 0.0102
CX599486.1 7.83 0.0042
Cartilage oligomeric matrix protein COMP CX592689.1 2.53 0.0036
CX592951.1 2.25 0.0014
CX593277.1 2.09 0.0164
CX597915.1 2.63 0.0041
CX600749.1 2.43 0.0035
CX601142.1 2.29 0.0038
Fibronectin FN1 CX594011.1 4.65 0.0075
CX596432.1 3.35 0.0192
CX598808.1 3.86 0.0313
CX600436.1 4.18 0.0024
CX601190.1 4.62 0.0017
CX602630.1 1.31 0.1717
peFN840 6.03 0.0013
peFN-C1 7.24 0.0018
Frizzled-related protein FRZB CX597477.1 3.53 0.0159
CX598716.1 3.82 0.0227
CX604177.1 2.70 0.0015
Heparan sulfate 3-O-sulfotransferase 3A1 HS3ST3A1 CX595901.1 2.61 0.0061
Matrix metalloproteinase 1 (collagenase) MMP1 peMMP1 4.61 0.0080
Nexin-1 PN-1 CX604123.1 2.27 0.0071
Procollagen C-endopeptidase enhancer 2 PCOLCE2 CX597547.1 4.63 0.0041
CX601347.1 2.08 0.0036
CX604313.1 1.89 0.0013
CX605197.1 4.64 0.0322
CX605337.1 4.31 0.0038
Serine proteinase inhibitor, clade A, member 5 SERPINA5 CX598843.1 3.27 0.0038
Sulfatase 1 SULF1 CX596711.1 2.83 0.0043
Tissue inhibitor of metallopeptidase 2 TIMP2 CX605012.1 4.48 0.0050
Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; GenBank ID: Accession number of equine cDNA 
spotted on the microarray (†: some IDs represent plasmid designation); Fold Change (A/N): Relative Adult/Neonate fold change; p-value: one-
sample t-test p-value for probe across the four biological replicates in the total sample set.Page 8 of 14
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Table 5: Transcriptional profiles of growth factors present on equine cDNA microarray
Gene Name Gene Symbol Total Probe Sets Median Fold Difference 
(N/A)
Probe sets with p < 0.01 Probe sets with p < 0.05
Bone morphogenetic protein 2 BMP2 6 0.99 0 1
Bone morphogenetic protein 4 BMP4 1 0.81 0 0
Bone morphogenetic protein 6 BMP6 1 0.79 0 0
Bone morphogenetic protein receptor 
1a
BMPR1A 1 0.91 0 0
Bone morphogenetic protein receptor 
2
BMPR2 2 0.73 0 0
Connective tissue growth factor CTGF 1 0.82 0 0
Fibroblast growth factor 2 FGF2 2 0.76 0 2
Fibroblast growth factor 10 FGF10 1 0.35 0 1
Fibroblast growth factor 18 FGF18 1 1.03 0 0
Fibroblast growth factor receptor 1 FGFR1 2 0.97 0 0
Fibroblast growth factor receptor 2 FGFR2 3 0.59 0 2
Fibroblast growth factor receptor 3 FGFR3 2 0.74 0 2
Fibroblast growth factor receptor-like 
1
FGFRL1 4 0.84 1 2
Growth differentiation factor 5 GDF5 1 0.90 1 1
Growth differentiation factor 6 GDF6 1 1.07 1 1
Growth differentiation factor 10 GDF10 2 0.74 0 1
Insulin-like growth factor 1 IGF1 1 0.89 0 1
Insulin-like growth factor receptor 1 IGFR1 2 0.86 0 0
Insulin-like growth factor 2 receptor IGF2R 1 1.12 0 1
Insulin-like growth factor binding 
protein 4
IGFBP4 1 0.83 0 0
Insulin-like growth factor binding 
protein 5
IGFBP5 3 1.05 1 1
Insulin-like growth factor binding 
protein 6
IGFBP6 1 0.78 0 0
Insulin-like growth factor binding 
protein 7
IGFBP7 3 0.85 0 1
Transforming growth factor β1 TGFβ1 2 1.11 0 0
Transforming growth factor β1-like 1 TGFβ1L1 2 0.98 0 0
Transforming growth factor β2 TGFβ2 5 0.96 0 1
Transforming growth factor β3 TGFβ3 2 0.86 0 0
Transforming growth factor β 
receptor 1
TGFβR1 1 0.73 0 0
Transforming growth factor β 
receptor 2
TGFβR2 1 0.70 0 0
Transforming growth factor β 
receptor 3
TGFβR3 5 0.45 3 5
Transforming growth factor β 
receptor associated protein 1
TGFβRAP1 1 0.91 0 0
Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; Total probe sets: Number of probe sets on the microarray representing the gene based on best 
BLAST match results; Median Fold Difference (N/A): Relative median Neonate/Adult fold change (bold represents fold difference > 2); Probe sets with p < 0.01 or 0.05: number of probe sets for 
each gene meeting these criteria by one-sample t-test.
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and hydroxylysyl aldehydes [33]. The condensation of
collagens helps increase tensile strength within cartilage.
As such, the upregulation of LOXL2 is likely necessary for
adaptation to shear and weight-bearing stresses. When
immature bovine articular cartilage is treated with the
lysyl oxidase inhibitor β-aminopropionitrile in an in vitro
model, a reduction of tensile integrity was noted [34].
These findings are consistent with neonatal expression of
collagen modifying enzymes in parallel to higher levels of
collagen synthesis during growth and biomechanical
adaptation.
Increased steady state levels of tenascin-C (TNC) tran-
scripts in neonatal cartilage are also consistent with a
remodeling process. This protein is upregulated in tissues
at developmental stages, during wound healing, and dur-
ing tumorigenesis [35-37]. TNC has an anti-adhesive N-
terminal domain and a pro-adhesive C-terminal domain;
its multiple domains allow for interactions with many
ECM components, including fibronectin [38,39]. Thus,
the presence of TNC affects cells within the ECM, notably
by inhibiting cell adhesion and focal adhesion kinase-sig-
naling while stimulating growth [35,37]. The effects of
TNC on matrix organization have been well characterized
in the developing chick forebrain, in healing skin wounds,
and in tumorigenesis [37,40]. Tenascin-C is expressed
within the developing limb; however, it disappears
throughout the limb and the growth plate during endo-
chondral ossification, though expression can still be
detected in postnatal articular cartilage [38,41]. As matu-
ration occurs in normal articular cartilage and the provi-
sional matrix is replaced by adapted anisogenous matrix,
TNC expression decreases [38,41]. The current data are
consistent with previous TNC findings for chicken,
mouse, and rat. Theories for the postnatal presence and
then reduction of TNC within the articular cartilage
include maintenance of the chondrocyte phenotype,
capability of the cells to attach and then detach in an
expanding matrix, and the utilization of signal transduc-
tion for mediating chondrocyte developmental fate [38].
Another interesting finding was elevated steady state lev-
els of transcripts encoding nidogen-2 (NID2) in neonatal
chondrocytes (Table 3). NID2 is one of the two nidogen
matrix-binding isoforms found to exist in mammals
which are involved in basement membrane assembly [42-
44]. Nidogens are typically localized to basement mem-
branes, but have also been associated with development
and tissue remodeling, including limb formation [45,47].
Thus far, it has been shown that nidogens interact with
perlecan, collagen types I and IV, integrins, and laminins
[44,45,48]. Matrix-binding proteins like nidogens also
have the capacity to play a role in the adaptive maturation
process of a growing neonate, which seems to be best
characterized by the expansion of collagens within the
provisional immature matrix and the modifications of the
matrix postnatally to withstand stresses.
The spectrum of upregulated transcripts in mature articu-
lar cartilage is consistent with chondrocytes that have
transitioned functionally from cartilage growth to carti-
lage maintenance. Besides elevated adult steady state tran-
script levels for matrix molecules like cartilage
intermediate layer protein (CILP), cartilage oligomeric
matrix protein (COMP), and fibronectin (FN), the data
also reveal other clones that contribute to the roles of
chondrocytes in mature cartilage (Tables 2 and 4). With
regards to matrix proteins, differences in levels of CILP
mRNA detected by microarray hybridization correspond
to previous reports of protein accumulation in the extra-
territorial matrix of adult cartilage with age [49]. It is
believed that this protein causes increased calcium pyro-
phosphate dihydrate deposition in cartilage, impairs
chondrocyte responsive to IGF-1, and subsequently hin-
ders matrix repair [50]. Moreover, increased levels of
mRNA encoding COMP were also found in adult carti-
lage; RT-qPCR quantified this difference as 3.5-fold (Fig-
ure 2). COMP is a homopentameric glycoprotein that
binds to type II collagen interterritorially to stabilize the
ECM [51,52]. COMP mRNA upregulation has been previ-
ously described during different stages of limb and joint
development with species-dependence as well as with
mechanical compression [52,53]. Increased fibronectin
mRNA hybridization in adult articular cartilage parallels
findings from Burton-Wurster et al. (Table 4) [54].
Fibronectin is an important extracellular matrix adhesion
glycoprotein for cell-matrix signaling. Besides genes
which encode matrix proteins, categories of many other
genes which typify the maintenance of a heterogeneous
matrix are represented. For example, genes with func-
tional roles in collagen-, glycosaminoglycan-, and prote-
oglycan-binding are upregulated in adult articular
chondrocytes (Table 4). Once cartilage growth and adap-
tation are complete, type II collagen expression is sus-
tained yet at lower levels as the chondrocyte's primary role
transforms to tissue maintenance. Increased mRNA levels
of matrix metalloproteinase-1 (MMP1), tissue inhibitor of
metallopeptidases-2 (TIMP2), and chondroprotective
nexin-1 (PN1) are also consistent with cartilage mainte-
nance (Table 4). With maturation, gene expression in
articular chondrocytes reflects tissue homeostasis and a
perpetuation of the ability to withstand shear and weight-
bearing stresses.Histological examination of articular car-
tilage reveals increased cellularity per unit volume of car-
tilage in neonatal animals compared to adults. A stable
chondrocyte number and expanding matrix may be a pri-
mary mechanism in achieving the lower cell density
observed in adult articular cartilage. In comparing pro- vs.
anti- cell proliferation, cell cycle, and apopoptic genes inPage 10 of 14
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RT-qPCR measurement of differential gene expressionFigure 2
RT-qPCR measurement of differential gene expression. Quantification of transcript abundance indicates significant up-
regulation of COMP (b) and TGFβR3 (e) gene expression in adult articular cartilage relative to neonatal articular cartilage. In 
contrast, gene expression for COL2A1 (a), P4HA1 (c), and TNC (d) are significantly up-regulated in neonatal articular cartilage 
relative to adult articular cartilage. Expression of TGFβ1 (f) was not significantly different between neonatal and adult samples. 
The RT-qPCR data for all six target genes confirm the results of microarray hybridization experiments. Data are presented as 
box and whisker plots indicating lowest value, first (0.25) quartile, median, third quartile (0.75), and highest value. Mathematical 
means of expression are indicated below each age group, and mean fold differences for each target gene are also given numer-
ically as "Mean FC" under the abscissa. ** (p < 0.01).
BMC Musculoskeletal Disorders 2008, 9:149 http://www.biomedcentral.com/1471-2474/9/149the transcriptional profiles, questions with regards to cell
proliferation and cell cycle regulation persist. From the
transcriptional profiles, it is difficult to say definitively at
either stage of maturation that the chondrocytes are in a
state of proliferation or quiescence. Relatively few probes
representing these functional categories were significantly
up-regulated in neonates. Moreover, though many more
(25) gene probes representing these ontology categories
were upregulated in adults, distribution did not favor cell
proliferation or growth factor activity. Growth factors
such as TGFβ1 and IGF1 have been shown to induce
chondrocyte proliferation and ECM production with limb
development and in culture, and the importance of fac-
tors and receptors like BMPR1A, GDF5, and TGFβR2 in
the maintenance of postnatal articular have also been
demonstrated [44,55-58]. However, FGF10 and TGFβR3
were the only genes related to growth factor activity with
> 2 fold difference between adult and neonatal articular
cartilage (Table 5). Increased steady state levels of TGFβR3
in articular cartilage for adults were validated by qPCR at
2.70-fold (p < 0.01). While transcript levels for growth
factors were relatively similar, it is possible that growth
factor activity in postnatal articular cartilage maturation is
regulated primarily at a post-transcriptional level. Growth
factors sequestered within the extracellular matrix of artic-
ular cartilage have been shown to become functionally
activated by enzymes like matrix metalloproteinases
[59,60].
A broad disparity existed in the number of differentially
expressed genes between neonates and adults (Figure 1c).
Of the 544 significant genes represented in the array data,
a majority (499 genes, or 91.7%) represented increased
steady state transcript levels in adult chondrocytes. This
difference could be explained by one of two theories. It is
possible that cellular activity is more complex in the adult
chondrocyte which is thus represented by an increased
abundance of transcripts. A second and perhaps more
likely explanation is that the discrepancy is accounted for
by an adult-biased representation of probe sets on the
microarray. Articular cartilage from the 15-month old
horse utilized in the generation of the cDNA library spot-
ted on the array likely reflects an adult articular chondro-
cyte transcriptome with neonate-specific transcripts
under-represented. Thus, it is possible that cell prolifera-
tion or cell cycle regulatory genes expressed in the neonate
were absent from the array and thus were unable to be
assessed. A further opportunity to extend the data from
the current study would be to conduct time course exper-
iments comparing transcriptional profiling data from
immature and adolescent ages to neonatal and adult sam-
ples, while including joint-specific and location-specific
comparisons in the articular cartilage maturation assess-
ment [61].
Conclusion
Previous studies of postnatal articular cartilage matura-
tion in mammals have focused on age-dependent changes
in the structural and biochemical organization of the
matrix. The current data extends this knowledge by using
transcriptional profiling to compare gene expression
between neonatal and adult chondrocytes in equine artic-
ular cartilage. Seven percent (642) of the 9,367 probe sets
on an equine-specific microarray were differentially
expressed (p < 0.01), organizing primarily into ontology
categories related to extracellular matrix, skeletal develop-
ment, and cell adhesion. Collagens, matrix-modifying
enzymes, and provisional matrix proteins were expressed
at higher levels in the articular cartilage of newborn foals.
Transcripts encoding leucine-rich small proteoglycans,
matrix assembly, and cartilage maintenance proteins were
found at higher steady state levels in adult articular
chondrocytes. Microarray data for COL2A1, COMP,
P4HA1, TGFB1, TGFBR3, and TNC were validated by
quantitative PCR. Overall, the findings support the
hypothesis that gene expression changes in articular carti-
lage during postnatal maturation reflect a functional tran-
sition of chondrocytes from growth and matrix synthesis
in the neonate to cartilage homeostasis in the adult.
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